PL4117706T3 - Fetuina a do leczenia zaburzeń czynności nerek - Google Patents

Fetuina a do leczenia zaburzeń czynności nerek

Info

Publication number
PL4117706T3
PL4117706T3 PL21710317.5T PL21710317T PL4117706T3 PL 4117706 T3 PL4117706 T3 PL 4117706T3 PL 21710317 T PL21710317 T PL 21710317T PL 4117706 T3 PL4117706 T3 PL 4117706T3
Authority
PL
Poland
Prior art keywords
fetuin
treatment
renal disorders
renal
disorders
Prior art date
Application number
PL21710317.5T
Other languages
English (en)
Inventor
Uyen HUYNH-DO
Stefan RUDLOFF
Original Assignee
Universität Bern
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universität Bern filed Critical Universität Bern
Publication of PL4117706T3 publication Critical patent/PL4117706T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1741—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals alpha-Glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL21710317.5T 2020-03-11 2021-03-11 Fetuina a do leczenia zaburzeń czynności nerek PL4117706T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20162490 2020-03-11
PCT/EP2021/056253 WO2021180884A1 (en) 2020-03-11 2021-03-11 Fetuin a for treatment of renal disorders

Publications (1)

Publication Number Publication Date
PL4117706T3 true PL4117706T3 (pl) 2025-01-27

Family

ID=69846218

Family Applications (1)

Application Number Title Priority Date Filing Date
PL21710317.5T PL4117706T3 (pl) 2020-03-11 2021-03-11 Fetuina a do leczenia zaburzeń czynności nerek

Country Status (12)

Country Link
US (1) US20230173025A1 (pl)
EP (1) EP4117706B1 (pl)
JP (1) JP7877217B2 (pl)
KR (1) KR20230024249A (pl)
CN (1) CN115243706A (pl)
AU (1) AU2021234121A1 (pl)
BR (1) BR112022015608A2 (pl)
CA (1) CA3168484A1 (pl)
DK (1) DK4117706T3 (pl)
ES (1) ES2994502T3 (pl)
PL (1) PL4117706T3 (pl)
WO (1) WO2021180884A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7740678B2 (ja) * 2021-02-04 2025-09-17 学校法人自治医科大学 腎障害を予防又は治療するための医薬
AU2024393727A1 (en) * 2023-12-05 2026-06-18 Previpharma Gmbh Fetuin-a for treating or preventing pathological inflammations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1191845A4 (en) 1999-04-13 2002-07-17 Long Island Jewish Res Inst PREVENTION OF BRAIN DAMAGE CAUSED BY ISCHEMIA
US7186555B1 (en) * 1999-04-13 2007-03-06 The Feinstein Institute For Medical Research Prevention of brain damage in stroke
PT1263464E (pt) 2000-03-09 2012-12-17 Genzyme Corp Utilização de anticorpos anti-tgf-beta antagonistas para tratar ou para prevenir a perda da função renal
US20030044400A1 (en) * 2001-05-22 2003-03-06 Jenny Yu Composition and method for treating cells
US20030180301A1 (en) * 2002-01-22 2003-09-25 Shaf Keshavjee Use of TGF-beta antagonists to treat or to prevent chronic transplant rejection
AU2004257367A1 (en) * 2003-07-16 2005-01-27 Resverlogix, Inc. Compounds and methods for downregulating the effects of TGF-beta
ES2356217B1 (es) * 2009-08-04 2012-02-13 Universidad De Salamanca Método para la detección de daño renal.
CN104007258B (zh) * 2013-09-30 2016-07-06 中国医学科学院基础医学研究所 局灶性节段性肾小球硬化的蛋白标志物

Also Published As

Publication number Publication date
WO2021180884A1 (en) 2021-09-16
JP7877217B2 (ja) 2026-06-22
US20230173025A1 (en) 2023-06-08
AU2021234121A1 (en) 2022-09-29
BR112022015608A2 (pt) 2022-09-27
KR20230024249A (ko) 2023-02-20
EP4117706A1 (en) 2023-01-18
CA3168484A1 (en) 2021-09-16
EP4117706B1 (en) 2024-09-04
CN115243706A (zh) 2022-10-25
JP2023517943A (ja) 2023-04-27
ES2994502T3 (en) 2025-01-24
DK4117706T3 (da) 2024-10-28

Similar Documents

Publication Publication Date Title
IL294594A (en) Methods of treating pemphigus
GB202004161D0 (en) Filter for a treatment apparatus
GB202020549D0 (en) Treatment for Lysine Degradation-associated Disorders
EP4118083A4 (en) PURIN COMPOUNDS FOR THE TREATMENT OF DISEASES
IL307607A (en) Tetracyclic compounds for the treatment of brain disorders
GB202105683D0 (en) Nebuliser outlet
GB2642168B (en) Nebuliser outlet
IL313920A (en) Treatment of heart and lung disorders
IL289221A (en) Compounds for the treatment of vision disorders
GB201914034D0 (en) Treatment of neurological disorders
IL319571A (en) R-Trihexyphenidyl for the treatment of movement disorders
GB202007082D0 (en) Assemblage for forming a treatment chair
GB202204231D0 (en) Retinal Disorders
DK4117706T3 (da) Fetuin A til behandling af nyrelidelser
IL288797A (en) Treatment of synoclinopathy
GB201908453D0 (en) Compounds for treating respiratory disease
GB202109021D0 (en) Treatment for autoimmune diseases
CA224043S (en) Shower filter
GB201905810D0 (en) Method of treatment
ZA202202813B (en) Simplified sulphate removal for effluent treatment
IL291639A (en) A method for treating mood disorders
GB202109675D0 (en) Treatment for tyrosine degradation-associated disorders
GB202214721D0 (en) A treatment for mental disorders
GB202204234D0 (en) Retinal Disorders
GB202204230D0 (en) Retinal Disorders